TY - JOUR
T1 - Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN)
T2 - A protocol for a multicenter longitudinal prospective observational study
AU - Roick, Julia
AU - Berner, Reinhard
AU - Bernig, Toralf
AU - Erdlenbruch, Bernhard
AU - Escherich, Gabriele
AU - Faber, Jörg
AU - Klein, Christoph
AU - Bochennek, Konrad
AU - Kratz, Christian
AU - Kühr, Joachim
AU - Längler, Alfred
AU - Lode, Holger N.
AU - Metzler, Markus
AU - Müller, Hermann
AU - Reinhardt, Dirk
AU - Sauerbrey, Axel
AU - Schepper, Florian
AU - Scheurlen, Wolfram
AU - Schneider, Dominik
AU - Schwabe, Georg Christof
AU - Richter, Matthias
N1 - Publisher Copyright:
© 2020 The Author(s).
PY - 2020/1/31
Y1 - 2020/1/31
N2 - Background: About 2000 children and adolescents under the age of 18 are diagnosed with cancer each year in Germany. Because of current medical treatment methods, a high survival rate can be reached for many types of the disease. Nevertheless, patients face a number of long-term effects related to the treatment. As a result, physical and psychological consequences have increasingly become the focus of research in recent years. Social dimensions of health have received little attention in health services research in oncology so far. Yet, there are no robust results that allow an estimation of whether and to what extent the disease and treatment impair the participation of children and adolescents and which factors mediate this effect. Social participation is of great importance especially because interactions with peers and experiences in different areas of life are essential for the development of children and adolescents. Methods: Data are collected in a longitudinal, prospective, observational multicenter study. For this purpose, all patients and their parents who are being treated for cancer in one of the participating clinics throughout Germany will be interviewed within the first month after diagnosis (t1), after completion of intensive treatment (t2) and half a year after the end of intensive treatment (t3) using standardized questionnaires. Analysis will be done by descriptive and multivariate methods. Discussion: The results can be used to identify children and adolescents in high-risk situations at an early stage in order to be able to initiate interventions tailored to the needs. Such tailored interventions will finally reduce the risk of impairments in the participation of children and adolescents and increase quality of life. Trial registration: ClinicalTrials.gov: NCT04101123.
AB - Background: About 2000 children and adolescents under the age of 18 are diagnosed with cancer each year in Germany. Because of current medical treatment methods, a high survival rate can be reached for many types of the disease. Nevertheless, patients face a number of long-term effects related to the treatment. As a result, physical and psychological consequences have increasingly become the focus of research in recent years. Social dimensions of health have received little attention in health services research in oncology so far. Yet, there are no robust results that allow an estimation of whether and to what extent the disease and treatment impair the participation of children and adolescents and which factors mediate this effect. Social participation is of great importance especially because interactions with peers and experiences in different areas of life are essential for the development of children and adolescents. Methods: Data are collected in a longitudinal, prospective, observational multicenter study. For this purpose, all patients and their parents who are being treated for cancer in one of the participating clinics throughout Germany will be interviewed within the first month after diagnosis (t1), after completion of intensive treatment (t2) and half a year after the end of intensive treatment (t3) using standardized questionnaires. Analysis will be done by descriptive and multivariate methods. Discussion: The results can be used to identify children and adolescents in high-risk situations at an early stage in order to be able to initiate interventions tailored to the needs. Such tailored interventions will finally reduce the risk of impairments in the participation of children and adolescents and increase quality of life. Trial registration: ClinicalTrials.gov: NCT04101123.
KW - Brain tumors
KW - Cancer
KW - Children and adolescents
KW - Leukemia
KW - Patient reported outcomes
KW - Sarcomas
KW - Social participation
UR - http://www.scopus.com/inward/record.url?scp=85078849761&partnerID=8YFLogxK
U2 - 10.1186/s12887-020-1943-3
DO - 10.1186/s12887-020-1943-3
M3 - Article
C2 - 32005112
AN - SCOPUS:85078849761
SN - 1471-2431
VL - 20
JO - BMC Pediatrics
JF - BMC Pediatrics
IS - 1
M1 - 48
ER -